| Literature DB >> 24923435 |
Oscar Ramirez, Iñigo Olalde, Jonas Berglund, Belen Lorente-Galdos, Jessica Hernandez-Rodriguez, Javier Quilez, Matthew T Webster, Robert K Wayne, Carles Lalueza-Fox, Carles Vilà, Tomas Marques-Bonet1.
Abstract
BACKGROUND: Although a variety of genetic changes have been implicated in causing phenotypic differences among dogs, the role of copy number variants (CNVs) and their impact on phenotypic variation is still poorly understood. Further, very limited knowledge exists on structural variation in the gray wolf, the ancestor of the dog, or other closely related wild canids. Documenting CNVs variation in wild canids is essential to identify ancestral states and variation that may have appeared after domestication.Entities:
Mesh:
Year: 2014 PMID: 24923435 PMCID: PMC4070573 DOI: 10.1186/1471-2164-15-465
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Chromosomal distribution of 860 CNVs in the canine genome. The chromosomes are represented by bars; colors indicate the location of the 860 CNVs. Red marks indicate dog-specific CNVs.
Summary of CNVs genotyped per sample
| Sample | Total CNVs | Unique CNVs* | ||||
|---|---|---|---|---|---|---|
| Total | Gains | Loses | Total | Gains | Loses | |
| Boxer | 153 | 88 | 65 | 19 | 8 | 11 |
| Dachshund | 218 | 92 | 126 | 7 | 2 | 5 |
| Beagle | 209 | 89 | 120 | 16 | 7 | 9 |
| Basenji | 267 | 90 | 177 | 32 | 8 | 24 |
| Dingo | 186 | 56 | 130 | 8 | 0 | 8 |
| IsraelWolf | 252 | 128 | 124 | 3 | 0 | 3 |
| IsraelWolf2 | 194 | 75 | 119 | 2 | 0 | 2 |
| ItalianWolf | 224 | 100 | 124 | 0 | 0 | 0 |
| ItalianWolf2 | 185 | 89 | 96 | 2 | 0 | 2 |
| PortugueseWolf | 202 | 77 | 125 | 5 | 2 | 3 |
| IberianWolf | 211 | 95 | 116 | 6 | 4 | 2 |
| YellowstoneWolf | 270 | 79 | 191 | 34 | 2 | 32 |
| GreatlakesWolf | 268 | 148 | 120 | 12 | 10 | 2 |
| IranianWolf | 209 | 80 | 129 | 0 | 0 | 0 |
| MexicanWolf | 211 | 93 | 118 | 2 | 0 | 2 |
| ChineseWolf | 181 | 73 | 108 | 0 | 0 | 0 |
| IndianWolf | 226 | 87 | 139 | 9 | 4 | 5 |
| MongolianWolf | 162 | 71 | 91 | 0 | 0 | 0 |
| MongolianWolf2 | 265 | 136 | 129 | 14 | 9 | 5 |
| SwedenWolf | 224 | 94 | 130 | 10 | 7 | 3 |
| RedWolf | 223 | 123 | 100 | 8 | 6 | 2 |
| Coyote | 200 | 94 | 106 | 4 | 1 | 3 |
| Golden Jackal | 215 | 103 | 112 | 22 | 4 | 18 |
*Unique are defined as CNV that are present only in one sample.
Figure 2CNV breakpoints composition analysis. A: Base composition of CNV breakpoints. GC-content in 400 bp windows around the breakpoint recorded at the center of each window. Negative locations represent windows inside the CNVs and colors represent the proportion of CNVs with a size that can cover a window at a specific distance inside the CNVs. B: Enrichment of L1 repeats in CNV breakpoints. Observed to expected ratios of 5 classes of differentially diverged L1 repeats in CNV breakpoints. Colors represent the size of the CNV breakpoint.
Figure 3Candidate CNVs selected during dog domestication. A: Values of V ST between dogs and wolves for the 860 regions (ordered by the V ST value). In red, the 25 regions with highest V ST values. B: Log2values of the region with highest V ST; dogs are represented in red. The CNV region (yellow) overlaps with the PDE4D gene (green).
List of top 25 most differentiated regions based on between dog and wild canids
|
| Chr | Start | End | Gene |
|---|---|---|---|---|
| 0.470 | chr2 | 49,686,866 | 49,714,373 | Phosphodiesterase 4D, cAMP-specific ( |
| 0.458 | chr8 | 63,053,405 | 63,054,226 | Echinoderm microtubule associated protein like 5( |
| 0.455 | chr9 | 20,104,325 | 20,942,683 | |
| 0.444 | chr34 | 15,222,600 | 15,228,141 | |
| 0.405 | chr3 | 56,422,480 | 56,425,666 | CREB regulated transcription coactivator 3( |
| 0.372 | chr18 | 57,419,688 | 57,432,938 | |
| 0.360 | chr10 | 11,064,284 | 11,065,425 | |
| 0.356 | chr10 | 37,202,529 | 37,206,649 | |
| 0.348 | chr6 | 40,916,498 | 40,919,469 | Zinc finger protein 500 ( |
| 0.346 | chr8 | 19,445,383 | 19,454,376 | |
| 0.313 | chr28 | 35,223,479 | 35,250,497 | Deleted in malignant brain tumors 1 ( |
| 0.303 | chr26 | 15,768,680 | 15,778,843 | |
| 0.301 | chr20 | 10,484,859 | 10,488,574 | Solute carrier family 6 (neurotransmitter transporter), member 11( |
| 0.297 | chr10 | 21,640,830 | 21,644,386 | |
| 0.279 | chr7 | 35,432,582 | 35,437,565 | Regulator of G-protein signaling 7 ( |
| 0.278 | chr22 | 34,304,138 | 34,305,222 | EDNRB antisense RNA 1 ( |
| 0.257 | chr28 | 16,096,188 | 16,106,945 | |
| 0.255 | chr5 | 38,737,275 | 38,738,036 | Dynein, axonemal, heavy chain 9 ( |
| 0.253 | chr6 | 50,243,863 | 50,244,363 | |
| 0.249 | chr26 | 31,903,962 | 31,981,330 | |
| 0.244 | chr14 | 3,093,975 | 3,101,514 | |
| 0.243 | chr8 | 11,405,495 | 11,411,624 | |
| 0.237 | chr11 | 45,618,474 | 45,621,740 | ELAV like neuron-specific RNA binding protein 2 ( |
| 0.236 | chr1 | 15,627,405 | 15,636,380 | |
| 0.226 | chr26 | 34,271,837 | 34,692,378 | Topoisomerase (DNA) III beta ( |